CME Group (CME) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 May, 2026Executive summary
Adjourned annual meeting for Class B Proposals and director elections will be held virtually on June 9, 2026, following failure to achieve a quorum at the original meeting.
Proxies previously submitted remain valid unless revoked or changed before the new voting deadline.
Results of the adjourned meeting will be filed with the SEC within four business days.
Voting matters and shareholder proposals
Shareholders are asked to vote on Items 4, 5, 6, and 7, which relate to Class B Proposals affecting board structure and director election processes.
Approval of proposals will trigger payments of $6,200 per Class B-1 share, $4,100 per Class B-2 share, and $2,000 per Class B-3 share to holders as of the record date.
Voting is available until 10:59 p.m. Central Time on June 8, 2026, with multiple options for participation.
Board of directors and corporate governance
Board recommends transitioning from exchange-specific director requirements to a single class of directors to better align with current market practices.
Proposed changes aim to broaden the pool of qualified nominees and reflect the company's evolution from a member-owned exchange to a global derivatives marketplace.
Board remains committed to strong member representation and expertise in market operations.
Latest events from CME Group
- Q2 2026 saw record revenue, strong market data growth, and robust shareholder returns.CME
Q2 202624 Jul 2026 - Record revenue, earnings, and trading volumes, with strong innovation and capital returns.CME
Q4 202522 Jul 2026 - Record Q1 2026 revenue and net income driven by surging global trading volumes and innovation.CME
Q1 202622 Jul 2026 - S&P 500 ESG Index rebranded as Scores and Screens, fueling growth in liquid ESG investment products.CME
Beyond ESG with Understanding the S&P 500 ESG Index Ecosystem Conference9 Jul 2026 - Strong volumes, new product launches, and tech-driven change shape a dynamic market outlook.CME
Piper Sandler Global Exchange and Trading Conference 20249 Jul 2026 - Record Q2 revenue, net income, and trading volumes with broad-based growth and innovation.CME
Q2 20248 Jul 2026 - Director election amendments failed; all nominated directors reelected; no shareholder questions.CME
AGM 20269 Jun 2026 - CFTC's Bitcoin perpetual approval sparks risk warnings amid new product launches and efficiency focus.CME
Piper Sandler Global Exchange and Fintech Conference4 Jun 2026 - Board candidates stress governance, risk oversight, and shareholder advocacy for the 2026 meeting.CME
Proxy filing16 Apr 2026